2'-chloro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] hydrochloride, 95.0%, 500mg

5-Chloropyrazine-2-carboxamide, 95.0%, 10g

2,4-DICHLORO-6-(METHYLTHIO)-5-NITROPYRIMIDINE, 95.0%, 1g

4-Bromo-1H-pyrrolo[3,2-c]pyridine, 95.0%, 1g

4-bromo-2-methoxy-6-nitroaniline, 97%, 25g

(S)-Benzyl 3-methylpiperazine-1-carboxylate, 95.0%, 1g

3-Methyl-4-phenyl-1H-pyrazole, 98.0%, 1g

1-(2-Methoxyphenyl)cyclobutane-1-carboxylic acid, 95.0%, 1g

(4S,7S,10S,13S)-7-(2-CARBOXYETHYL)-4-(CARBOXYMETHYL)-13-FORMYL-10-ISOPROPYL-2,5,8,11-TETRAOXO-3,6,9,12-TETRAAZAPENTADECAN-15-OIC ACID, 95%, 1mg

Methyl 1-methyl-1H-pyrrole-3-carboxylate, 97%, 5g

5-Methylpyrazine-2,3-dicarboxylic acid, 95+%, 250mg

4-nitrofenol, mínimo 99 %, para síntesis, 100 g, envase de vidrio

4-Fluoro-3-methoxy-5-(methylthio)benzaldehyde, 98%, 250mg